NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/04/2025
Voltar para busca
Dado oficial do USPTO
EPROTEIN DISCOVERY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EPROTEIN DISCOVERY
ST13
US500000079381392Classe
1, 5, 9, 10
Pedido
79381392
Registro
7741432
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
25/07/2023
Data de registro
01/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
DAVIS, ALEXIS A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Nuclera Ltd
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for scientific purposes; chemical preparationsenzymesgene editing enzymesoligonucleotidesproteins for scientific and industrial purposes; genesDNA and RNA being nucleic acid sequences for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNAsynthetic RNA and synthetic genes being nucleic acid sequences for scientific and industrial purposes; synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicalsreagents and enzymes for use in the preparation and creation of synthetic DNAsynthetic RNAsynthetic genes being nucleic acid sequences for scientific and industrial purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemicalbiological and biochemical reagents used for the synthesis of DNARNAoligonucleotidesgenes and proteins for scientific and industrial purposes
Classe 5
Biologicalchemical and biochemical reagentsproteinsgene editing enzymesall for medical diagnostic use; synthetic proteins for medical diagnostic use; vaccines
Classe 9
Scientific laboratory apparatus and instrumentsscientific desktop instruments for DNARNAgene and protein synthesis for scientific use; scientific desktop instruments for DNARNAgene and protein synthesismicrofluidic devices; medical laboratory research instruments in the nature of desktop instrument cartridges for use in scientific apparatus in connection with DNARNAgenecell and protein synthesis and characterization instrumentsnamely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors in the nature of sensor chips for scientificresearch or industrial purposes in DNARNAgene and protein synthesis; biochips in the nature of microchips; scientific research and laboratory apparatusapparatus and instruments for amplifying DNA and RNAreactorsbioreactorslaboratory apparatus and instruments for amplifying DNA and RNA using thermocyclersnot for medical purposes; apparatus and instruments for synthesising DNA and RNAmicroarraysscientific desktop instrumentsdesktop instrument cartridgessemiconductorssemiconductor chipsmicrochipsbio sensorsbio-chipsnot for medical purposes; scientific research and laboratory apparatusapparatus and instruments for processing DNA and RNAnamely scientific desktop instrumentsdesktop instrument cartridgessemiconductorssemiconductor chipsmicrochipsbiosensorsbiochips; computer hardware; recorded computer softwaredownloadable computer software and bioinformatics software for use in DNARNAgene and protein synthesis in the fields of biotechnologydrug discovery and medical science; all of the foregoing for use in DNARNAgene and protein synthesis in the fields of biotechnology and medical science
Classe 10
Medical apparatus and instruments used for DNA and RNA testing and analysis and genetic testingall for medical purposes; apparatus and instruments for DNA and RNA analysisDNA and RNA sequencing and protein synthesis in the nature of microfluidic chipsmicrofluidic cartridgesmicro-electromechanical chipsbio sensorsbio-chips for medical and veterinary purposes; apparatus for DNARNAgene and protein synthesis in the nature of microfluidic chipsmicrofluidic cartridgesmicro-electromechanical chipsbio sensorsbio-chips for medical and veterinary purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2025
PUBO
PUBLISHED FOR OPPOSITION
11/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/12/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/12/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/12/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/12/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
26/08/2024
GNFR
FINAL REFUSAL E-MAILED
26/08/2024
CNFR
FINAL REFUSAL WRITTEN
26/08/2024
RFNP
REFUSAL PROCESSED BY IB
17/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2024
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
16/07/2024
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
16/07/2024
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
16/07/2024
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
16/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/06/2024
RFNT
REFUSAL PROCESSED BY IB
02/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/03/2024
RFRR
REFUSAL PROCESSED BY MPU
11/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2024
CNRT
NON-FINAL ACTION WRITTEN
10/02/2024
DOCK
ASSIGNED TO EXAMINER
05/02/2024
MAFR
APPLICATION FILING RECEIPT MAILED
24/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EPROTEIN DISCOVERY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.